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Edited by Lukas HuberAbstract LRP6 is a Wnt coreceptor at the cell surface. Here,
we report that a specialized molecular chaperone Mesd modu-
lates LRP6-mediated Wnt signaling and how diﬀerent LRP6
mutants exhibit diﬀerential eﬀects on Wnt signaling. We found
that overexpression of increasing amounts of the full-length
LRP6 enhances Wnt signaling in a dose dependent manner only
in the presence of a co-expression of the molecular chaperone
Mesd, which promotes LRP6 folding and maturation to the cell
surface. We also demonstrated that LRP6 mutant lacking the
intracellular domain impedes LRP6 cell surface expression and
Wnt signaling in a dominant-negative fashion by sequestering
Mesd from promoting LRP6 folding. Our results present novel
mechanisms by which Mesd and LRP6 modulate Wnt signaling.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The low-density lipoprotein receptor (LDLR)-related pro-
tein-5 (LRP5) and LRP6 are two members of the expanding
LDLR family, which are a group of cell surface endocytosis
receptors that are able to bind and internalize a wide array
of extracellular ligands [1–3]. One of the predominant charac-
teristics of the LDLR family members is the presence of multi-
ple classes of conserved modules that include the b-propeller/
epidermal growth factor (EGF) modules and clusters of cys-
teine-rich ligand-binding repeats. LRP5/6 has four b-propel-
ler/EGF modules and three ligand-binding repeats [4–6]. All
the currently characterized extracellular ligands of LRP5/6
bind to the b-propeller/EGF repeat modules [7–10], whereasAbbreviations: EGF, epidermal growth factor; ER, endoplasmic reti-
culum; LDLR, low-density lipoprotein receptor; LRP6, LDLR-related
protein-6; RAP, receptor-associated protein; SDS–PAGE, sodium
dodecyl sulfate–polyacrylamide gel electrophoresis
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doi:10.1016/j.febslet.2006.09.011ligands for other LDLR family members typically bind to
the clusters of ligand-binding repeats [2,3].
A common feature that is shared by most members of the
LDLR family is their ability to bind the receptor-associated
protein (RAP) [11]. RAP is an endoplasmic reticulum (ER)-
resident protein that functions in receptor folding and traﬃck-
ing along the secretory pathway. Upon binding to receptors
following their translation, RAP promotes receptor folding.
In addition, RAP universally antagonizes ligand binding to
these receptors [11]. Another chaperone that is speciﬁcally
required for the biogenesis of the LDLR family members,
termed Boca/Mesd, was recently described [12,13]. It was sub-
sequently shown that Boca/Mesd promotes the proper folding
of the b-propeller/EGF repeat modules of LRP5/6 [14]. More
recently, we found that Mesd, like RAP, binds to cell surface
LRP5/6 and antagonizes ligand binding [15].
The canonical Wnt signaling pathway is involved in various
diﬀerentiation events during embryonic development and can
lead to tumor formation when aberrantly activated [16,17].
Studies in the past several years have demonstrated that
LRP5 and LRP6 are indispensable co-receptors of the canon-
ical Wnt pathway by interacting with several key components
of the Wnt/b-catenin signaling pathway [1,18]. Interestingly, it
has been found that LRP5/6 mutant lacking the cytoplasmic
tail is a dominant negative mutant for Wnt/b-catenin signaling
[19–22], whereas LRP5/6 mutant without the extracellular do-
main is a constitutive activator [9,19,23,24]. These two types of
LRP5/6 mutants are frequently used in Wnt signaling studies
in many areas including embryonic development and tumori-
genesis [5,9,19,21,22,24]. However, the mechanism by which
LRP5/6 dominant negative mutants block Wnt signaling was
unclear. In the present study, we further characterized Wnt sig-
naling mediated by LRP6, and found that both the extracellu-
lar domain and the cytoplasmic tail of LRP6 are required for
eﬃciently Wnt signaling, and that LRP6 mutant lacking the
cytoplasmic tail could impede LRP6 expression and function
through sequestering Mesd protein.2. Materials and methods
2.1. Constructs
Plasmid pCS-Myc-hLRP6 containing the full-length human LRP6
cDNA was kindly provided by Dr. Christof Niehrs (Deutsches Krebsf-
orschungszentrum, Heidelberg, Germany). Plasmid pCS-VSVG-
LRP6DC (hLRP6 mutant lacking cytoplasmic tail) was describedblished by Elsevier B.V. All rights reserved.
Fig. 1. The full-length LRP6 is more eﬃcient to induce Wnt signaling
than its mutant lacking the extracellular domain. (A) Schematic
representation of the full-length LRP6 and its mutants. (B) Wnt-
signaling induced by LRP6 and its mutant LRP6DN. HEK293 cells in
6-well plates were transfected with 0.2 lg of the full-length LRP6
expressing vector, LRP6DN expressing vector, or an empty vector,
together with 0.1 lg of the TOP-FLASH luciferase construct and
0.1 lg of a b-galactosidase-expressing vector in each well. The
luciferase activity was measured 48 hours after transfection. Values
are the average of triple determinations with the S.D. indicated by
error bars.
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(LRP6DN) was constructed by PCR. This mutant is comprised human
LRP6 signal peptide, 13 amino acid residues of the extracellular
domain (four amino acid residues immediately after LRP6 signal
peptide and nine amino acid residues immediately before the trans-
membrane domain), the transmembrane domain, and the entire cyto-
plasmic tail. The Myc epitope was inserted among 13 amino acid
residues of LRP6 extracellular domain. The primers for PCR reaction
are forward 5 0-GATCGGATCCATGGGGGCCGTCCTGAGGAG-
CCTCCTGGCCTGCAGCTTCTGTGTGCTCCTGAGAGCGGCC-
CC TTTGTTGCTTGAACAAAAACTCATCTCAGAAGAGGAT-
CTGGAAGAACCAGCACCACAGGCCAC-3 0, and reverse 5 0-GA-
TCTCTAGATCAGGAGGAGTCTGTACAGGGAG-3 0. The result-
ing PCR product was digested with BamHI and XbaI, and ligated into
pcDNA3 vector. The integrity of the construct was conﬁrmed by se-
quence analysis. Mouse Mesd in TOPO pcDNA3.1/V5 His vector
was obtained from Dr. Bernadette Holdener (State University of
New York at Stony Brook, Stony Brook, NY).
2.2. Cell culture and transfection
HEK293 cells were cultured in Dulbecco’s minimum essential med-
ium supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
100 U/ml of penicillin, 100 lg/ml of streptomycin, and maintained at
37 C in humidiﬁed air containing 5% CO2. For transfection, cells were
trypsinized and seeded into 6-well plates (2.0 · 105 cells/well) without
antibiotics. After 24 h, cells were transfected with various plasmids
using FuGENE 6 (Roche) according to manufacturer’s speciﬁcations.
Cells were harvested for analysis 48 h after transfection.
2.3. Luciferase reporter assay
HEK293 cells were plated into 6-well plates. For each well, 0.1 lg of
the TOP-FLASH luciferase construct (Upstate Biotechnology) was
cotransfected with 0.1–1.6 lg of the full-length LRP6-expressing vec-
tor, LRP6 mutant expressing vector, Mesd expressing vector, or the
empty pcDNA3 vector. A b-galactosidase-expressing vector (Promega,
Madison, WI) was included as an internal control for transfection eﬃ-
ciency. After 48 h, cells were lysed, and luciferase activity was deter-
mines as described before [15].
2.4. Co-immunoprecipitation
Cells in 6-well plates were lysed with 0.5 ml of lysis buﬀer (phos-
phate-buﬀered saline containing 1% Triton X-100 and 1 mM phenyl-
methylsulfonyl ﬂuoride). Each aliquot of cell extracts (400 lg of
protein) was brought to 0.5 ml with lysis buﬀer and mixed with
0.5 ml of phosphate-buﬀered saline containing 1% Triton X-100,
0.1% sodium dodecyl sulfate (SDS), 0.5% bovine serum albumin,
and 1 mM phenylmethylsulfonyl ﬂuoride (immunomixture), and then
incubated with antibody for 2 h at 4 C. Immunocomplexes were
precipitated with protein A-agarose beads for 45 min, washed three
times with immunomixture and two times with phosphate-buﬀered
saline buﬀer, and boiled in SDS sample buﬀer containing b-mercap-
toethanol. The supernatants were subjected to sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE) and Western
blotting.
2.5. Western blotting
HEK293 cells transiently transfected with Myc-tagged LRP6,
VSVG-tagged LRP6DC, or Flag-tagged Mesd were lysed with 0.5 ml
of lysis buﬀer at 4 C for 30 min. Equal quantities of protein were sub-
jected to SDS–PAGE under non-reducing conditions. Following trans-
fer to immobilon-P transfer membrane, successive incubations with
anti-Myc antibody (Roche), anti-VSVG antibody (Roche), anti-Flag
antibody (Sigma), or anti-actin antibody (Sigma), and horseradish per-
oxidase-conjugated secondary antibody were carried out for 60 min at
room temperature. The immunoreactive proteins were then detected
using the ECL system.
2.6. Cell surface ligand binding assay
Mouse recombinant Mesd protein was expressed and isolated as de-
scribed previously [15]. Carrier-free Na125I was purchased from NEN
Life Science Products. IODO-GEN was from Pierce. Mesd was iodin-
ated by using the IODO-GEN method as described previously [15].
Cell surface 125I-Mesd binding assay was performed essentially as de-
scribed [15].3. Results
3.1. The full-length LRP6 is more eﬃcient to induce Wnt
signaling than its mutant lacking the extracellular domain
To fully understand the roles of LRP6 in Wnt signaling, we
constructed a LRP6 mutant LRP6DN, which is comprised of
LRP6 cytoplasmic tail, transmembrane domain, and only 13
amino residues of the extracellular domain (Fig. 1A).
HEK293 cells in 6-well plates were transiently transfected with
0.2 lg of plasmid for the full-length LRP6 or LRP6DN, and
Wnt signaling was analyzed by TOP-FLASH luciferase repor-
ter assay. Interestingly, LRP6-transfected cells exhibited 12-
fold greater TOP-FLASH luciferase activity than the control
cells, whereas LRP6DN transfected cells did not display much
change of the luciferase activity when compared to the LRP6
transfected cells (Fig. 1B). These results suggest that the full-
length LRP6 is more eﬃcient to induce Wnt signaling than
the mutant lacking the extracellular domain. The strong
LRP6-induced Wnt signaling is probably caused by the inter-
action between endogenous Wnt proteins and the receptor.
3.2. Dose-dependent increase in Wnt signaling induced by
LRP6DN, but not the full-length LRP6
To further characterize the function of LRP6 and its mutant
LRP6DN in Wnt signaling, we performed TOP-FLASH lucif-
erase reporter assay after HEK293 cells were transiently trans-
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LRP6DN. We found that Wnt signaling induced by LRP6DN
was dose dependent, and that HEK293 cells transfected with
1.6 lg of LRP6DN plasmid exhibited a 23-fold greater activity
than the control cells (Fig. 2). However, Wnt signaling induced
by the full-length LRP6 did not display a dose dependent pat-
tern. TOP-FLASH luciferase activity was slightly increased
with the increased amounts of transfected LRP6 plasmid at
ﬁrst, but started to drop as the amounts of transfected LRP6
plasmid increased further. HEK293 cells transfected with
1.6 lg of LRP6 plasmid per well exhibited only a 10-fold great-
er activity than the control cells, which was signiﬁcantly lower
than the activity observed in HEK293 cells transfected with
0.4 lg of LRP6 plasmid per well (Fig. 2). These results suggest
that a regulatory mechanism is in place to restrict the extent of
LRP6-induced Wnt signaling, and that LRP6DN can escape
this regulation.
3.3. Mesd promotes LRP6 expression on the cell surface and
enhances Wnt signaling induced by LRP6
Mesd is a special chaperone for LRP5 and LRP6 [12–14]. As
the Wnt signaling induced by LRP6 did not exhibit a dose
dependent manner, we then studied the eﬀect of Mesd expres-
sion on LRP6-induced Wnt signaling. As shown in Fig. 3A,
with Mesd co-expression, Wnt signaling induced by LRP6
was gradually increased with the increasing amounts of
LRP6 transfected into HEK293 cells. Consistent with previous
studies [12–14], we found that the amounts of the LRP6 ma-
ture form were signiﬁcantly increased in the presence of Mesd
co-expression (Fig. 3B). It is generally believed that only cell
surfaceLRP6 has function in inducing Wnt signaling [12–
14,25]. In our previous study, we found that Mesd is a unique
LRP6 ligand and binds to cell surface LRP6 with high aﬃnity
(Kd  3.3 nM) [15]. To examine whether Mesd co-expressionFig. 2. Wnt signaling induced by overexpression of LRP6 mutant
lacking the extracellular domain, but not of the full-length LRP6,
exhibits a dose dependent manner. HEK293 cells in 6-well plates were
transfected with 0.1–1.6 lg of the full-length LRP6 expressing vector,
LRP6DN expressing vector, or LRP6DC expressing vector, together
with 0.1 lg of the TOP-FLASH luciferase construct and 0.1 lg of a b-
galactosidase-expressing vector in each well. The cells in each well were
transfected with the same amounts of plasmid DNAs (1.8 lg/well) by
balancing with the empty vector. The luciferase activity was measured
48 h after transfection. Values are the average of triple determinations
with the S.D. indicated by error bars.
Fig. 3. Mesd promotes LRP6 expression on the cell surface and
enhances Wnt signaling induced by LRP6. (A) Mesd enhances Wnt
signaling induced by LRP6. HEK293 cells in 6-well plates were
transiently transfected with LRP6 (0.1–0.8 lg/well), the TOP-FLASH
luciferase construct (0.1 lg/well), and a b-galactosidase-expressing
vector (0.1 lg/well), with the co-transfection of either empty pcDNA3
vector or pcDNA3-Mesd (0.8 lg/well). The cells in each well were
transfected with the same amounts of plasmid DNAs (1.8 lg/well) by
balancing with the empty vector. The luciferase activity was measured
48 h after transfection. Values are the average of triple determinations
with the S.D. indicated by error bars. (B) Mesd promotes LRP6
maturation. HEK293 cells in 6-well plates were transiently transfected
with LRP6 (Myc-tagged, 0.2–0.8 lg/well), with the co-transfection of
either empty pcDNA3 vector, or pcDNA3-Mesd (0.8 lg/well). Forty-
eight hours after transfection, the cells were lysed and the level of the
full-length LRP6 was examined by Western blot analysis with anti-
Myc antibody. The samples were also probed with an anti-actin
antibody to verify equal loading. (C) Mesd promotes LRP6 expression
on the cell surface. HEK293 cells in 6-well plates were co-transfected
with LRP6 (0.4 lg/well) and Mesd (0.2–0.8 lg/well). The cells in each
well were transfected with the same amounts of plasmid DNAs (1.2 lg/
well) by balancing with the empty vector. Forty-eight hours after
transfection, cells were incubated with 125I-Mesd (5 nM) at 4 C for 3 h
in the absence or the presence of 500 nM unlabeled Mesd. Cell surface
bound 125I-Mesd was determined as described in Section 2. Values are
the average of speciﬁc binding from triple determinations with the S.D.
indicated by error bars.
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LRP6 ligand binding assay. We found that cell surface 125I-
Mesd binding was gradually increased when LRP6 was co-
transfected with increasing amounts of Mesd-expressing vector
in HEK293 cells (Fig. 3C). Taken together, these results indi-
cate that Mesd co-expression promotes LRP6 expression on
the cell surface, which in turn enhances LRP6-induced Wnt
signaling. We noted that Mesd co-expression induced a higher
degree of the Wnt signaling increase (Fig. 3A) than the cell sur-
face LRP6 expression change (Fig. 3B), suggesting that LRP6-
induced Wnt signaling is ampliﬁed by other compounds of the
Wnt signaling pathway.
3.4. Mesd can rescue Wnt signaling blocked by LRP6 mutant
lacking the cytoplasmic tail
It has been reported that a LRP6 mutant lacking the intracel-
lular domain is defective in Wnt signaling, and functions as a
dominant-negativemutant [19–22]. Consistent with previous re-
sults, we found that LRP6DC,which encodes the entire extracel-
lular domain and transmembrane domain, inhibited LRP6-
induced Wnt signaling (Fig. 4A). In addition, we found that
the level of the full-length LRP6 expression was gradually de-Fig. 4. LRP6 mutant lacking the intracellular domain blocks the full-
length LRP6 expression and Wnt signaling. (A) LRP6DC blocks Wnt
signaling induced by the full-length LRP6. HEK293 cells in 6-well
plates were co-transfected with LRP6 (0.2–0.8 lg/well), LRP6DC (0.1–
0.4 lg/well), the TOP-FLASH luciferase construct (0.1 lg/well), and a
b-galactosidase-expressing vector (0.1 lg/well). The cells in each well
were transfected with the same amounts of plasmid DNAs (1.4 lg/well)
by balancing with the empty vector. The luciferase activity was
measured 48 h after transfection. Values are the average of triple
determinations with the S.D. indicated by error bars. (B) LRP6DC
blocks the full-length LRP6 expression. HEK293 cells in 6-well plates
were co-transfected with LRP6 (Myc-tagged, 0.2 lg/well), and
LRP6DC (0.1–0.8 lg/well). The cells in each well were transfected
with the same amounts of plasmid DNAs (1.0 lg/well) by balancing
with the empty vector. 48 h after transfection, the cells were lysed, and
the level of the full-length LRP6 was examined by Western blot
analysis with anti-Myc antibody. The samples were also probed with
an anti-actin antibody to verify equal loading.
Fig. 5. Mesd interacts with LRP6DC and promotes LRP6DC matu-
ration. (A) Mesd co-immunoprecipitates with LRP6DC. HEK293 cells
in 6-well plates were transiently transfected with LRP6 (Myc-tagged,
1 lg/well) or LRP6DC (VSVG-tagged, 1 lg/well), with the co-trans-
fection of either empty pcDNA3 vector, or pcDNA3-Mesd (Flag-
tagged, 1 lg/well). Forty-eight hours after transfection, the cells were
lysed and were immunoprecipitated with anti-Flag antibody or normal
mouse IgG, and then probed with anti-Myc antibody to detect LRP6,
or anti-VSVG antibody to detect LRP6DC. IP, immunoprecipitation;
WB, Western blot. (B) Mesd promotes LRP6DC maturation. HEK293
cells in 6-well plates were transiently transfected with LRP6DC
(VSVG-tagged, 0.6 lg/well), with the co-transfection of either empty
pcDNA3 vector, or pcDNA3-Mesd (1.0 lg/well). Forty-eight hours
after transfection, the cells were lysed and the LRP6DC expression was
examined by Western blot analysis with anti-VSVG antibody. The
samples were also probed with an anti-actin antibody to verify equal
loading.creased with the increased amounts of LRP6DC plasmid co-
transfected into HEK293 cells (Fig. 4B). We hypothesized that
LRP6DC could impede LRP6 expression and function through
sequestering LRP6 special chaperone Mesd. We then tested
whether Mesd interacts with LRP6DC, and is required for
LRP6DC folding and maturation. Co-immunoprecipitation
results demonstrated that LRP6DC, like the full-length LRP6,
interacts with Mesd (Fig. 5A). We also found that Mesd co-
expression enhanced LRP6DC maturation (Fig. 5B). Further-
more, when HEK293 cells were co-transfected with Mesd,
LRP6-inducedWnt signaling blocked by LRP6DCwas partially
rescued (Fig. 6A), and the expression of the full-length LRP6
mature form was partially restored too (Fig. 6B). Together,
these data suggest that LRP6DC inhibits LRP6-mediated Wnt
signaling by competing with LRP6 for binding to the folding
chaperone Mesd.4. Discussion
The complex structures of the LDLR family members,
including cysteine-rich repeats and b-propeller-like structures,
determine that both general ER chaperones and those special-
ized for the LDLR family members are involved in promoting
Fig. 6. Mesd can partially restore the full-length LRP6 expression and
rescue Wnt signaling blocked by LRP6 mutant lacking the cytoplasmic
tail. (A) Mesd rescues LRP6-induced Wnt signaling blocked by
LRP6DC. HEK293 cells in 6-well plates were co-transfected with
LRP6 (0.2 lg/well), LRP6DC (0.1–0.4 lg/well), Mesd (0.8 lg/well), the
TOP-FLASH luciferase construct (0.1 lg/well), and a b-galactosidase-
expressing vector (0.1 lg/well). The cells in each well were transfected
with the same amounts of plasmid DNAs (1.6 lg/well) by balancing
with the empty vector. The luciferase activity was measured 48 h after
transfection. Values are the average of triple determinations with the
S.D. indicated by error bars. (B) Mesd restores the full-length LRP6
expression. HEK293 cells in 6-well plates were co-transfected with
LRP6 (Myc-tagged, 0.2 lg/well), LRP6DC (0.2 lg/well), and Mesd
(0.8 lg/well). The cells in each well were transfected with the same
amounts of plasmid DNAs (1.2 lg/well) by balancing with the empty
vector. Forty-eight hours after transfection, the cells were lysed and the
level of the full-length LRP6 was examined by Western blot analysis
with anti-Myc antibody. The samples were also probed with an anti-
actin antibody to verify equal loading.
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and three ligand binding repeats [4–6]. The formation of cor-
rect disulﬁde bonds during receptor folding presents a chal-
lenging task for ER chaperones. The function of Mesd (as
well as RAP) during folding may be primarily to inhibit indis-
criminate disulﬁde bond formation, in particular inter-mole-
cularly between diﬀerent receptor molecules during and after
their translation [11]. Speciﬁcally, Mesd is required for the
maturation of these b-propeller/EGF modules through the
secretory pathway [12–14]. In the present study, we provided
new evidence that Mesd is a crucial protein for Wnt signaling.
We demonstrated that Mesd co-expression is required for
LRP6 expression and function at the cell surface, and that
LRP6 mutant lacking the cytoplasmic tail could impede
LRP6 expression and function through sequestering Mesd pro-
tein.
RAP is another specialized molecular chaperone for the
members of the LDLR family [11]. RAP binds with high aﬃnityto most members of the LDLR family [11], but a lower aﬃnity
to LRP6 [15]. In the present study, we found that RAP co-
expression had no signiﬁcant eﬀect on LRP6 folding and
LRP6-induced Wnt signaling (data not shown), suggesting that
RAP is not a critical specialized molecular chaperone for LRP6.
It is well established that RAP is a unique receptor antago-
nist for the LDLR family members. RAP can bind to cell sur-
face receptors of the LDLR family, and is able to inhibit the
binding of most currently known ligands of the LDLR family
members [11]. Recently, we found that Mesd, like RAP, is
capable of binding mature LRP6 at the cell surface and antag-
onizing ligand binding [15]. Depending on the nature of the
LRP6 ligands, exogenously added recombinant Mesd protein
can either upregulate or downregulate Wnt signaling. For
example, Mesd can block the binding of Dickkopf 1 (Dkk1),
a major secreted Wnt signaling antagonist [15]. In the present
study, we provide new evidence that Mesd is a crucial protein
for LRP6-mediated Wnt signaling at the cell surface. Thus,
Mesd can modulate LRP6 activity by promoting its folding in-
side the cells and ligand binding capacity at the cell surface.
LRP6 constructs lacking their extracellular domain are able
to activate the Wnt/b-catenin signaling in a Fz- and ligand-
independent manner [9,19,23,24]. It was shown that a PPSPXS
motif, which is reiterated ﬁve times in the LRP6 intracellular
domain and is conserved between LRP5, LRP6, and their Dro-
sophila homolog, Arrow, is necessary and suﬃcient to trigger
Wnt/b-catenin signaling [24,26]. In the present study, we found
that LRP6DN induced Wnt signaling in a dose-dependent
manner (Fig. 2). LRP6DN lacks the complex structures such
as cysteine-rich repeats and b-propeller-like structures, thus it
is not surprising that Mesd co-expression is not required for
LRP6DN signaling (data not shown). In the present study,
we also found that the full-length LRP6 is more eﬃcient to in-
duce Wnt signaling than its mutant lacking the extracellular
domain. Our data support the notion that both the extracellu-
lar domain and cytoplasmic tail of LRP6 are required for eﬃ-
ciently inducing Wnt signaling through LRP6, although the
LRP5/6 mutants lacking the cytoplasmic tail exhibit inhibitory
eﬀects on the Wnt signaling [1].
The inhibitory activity of LRP5/6 mutant lacking the cyto-
plasmic tail is upstream in the Wnt/b-catenin pathway [19–
22]. There might be several mechanisms by which this mutant
serves as a dominant negative mutant for Wnt/b-catenin sig-
naling. Firstly, the extracellular domain of LRP5/6 may work
as an autoinhibitory domain [9,27]. It has been reported that
the extracellular domain of the receptor might inhibit signaling
by oligomerization [27]. Secondly, LRP5/6 mutant lacking the
cytoplasmic tail could block Wnt signaling by sequestering
LRP5/6 ligands Wnt proteins [22], as LRP5/6 mutants lacking
the cytoplasmic tail are likely to retain the ability to bind
LRP5/6 ligands. Finally, our present study indicates that
sequestering special chaperone Mesd and impeding wild-type
LRP6 expression could be the third and perhaps the most
important mechanism by which the LRP5/6 mutant lacking
the cytoplasmic tail to inhibit Wnt signaling in a dominant-
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